BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8322081)

  • 1. Carisoprodol (Soma): a new and cautious perspective on an old agent.
    Littrell RA; Hayes LR; Stillner V
    South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carisoprodol: a drug of continuing abuse.
    Reeves RR; Pinkofsky HB; Carter OS
    J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carisoprodol: update on abuse potential and legal status.
    Reeves RR; Burke RS; Kose S
    South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carisoprodol: abuse potential and withdrawal syndrome.
    Reeves RR; Burke RS
    Curr Drug Abuse Rev; 2010 Mar; 3(1):33-8. PubMed ID: 20088817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meprobamate dependence secondary to carisoprodol (Soma) use.
    Littrell RA; Sage T; Miller W
    Am J Drug Alcohol Abuse; 1993; 19(1):133-4. PubMed ID: 8438828
    [No Abstract]   [Full Text] [Related]  

  • 7. Carisoprodol withdrawal after internet purchase.
    Eleid MF; Krahn LE; Agrwal N; Goodman BP
    Neurologist; 2010 Jul; 16(4):262-4. PubMed ID: 20592570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment due to intake of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J
    Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults.
    Lewandowski TA
    Hum Exp Toxicol; 2017 Aug; 36(8):846-853. PubMed ID: 27758843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose carisoprodol during pregnancy and lactation.
    Briggs GG; Ambrose PJ; Nageotte MP; Padilla G
    Ann Pharmacother; 2008 Jun; 42(6):898-901. PubMed ID: 18460586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic dysfunction during carisoprodol cessation: evidence for a carisoprodol withdrawal syndrome.
    Reeves RR; Parker JD
    J Am Osteopath Assoc; 2003 Feb; 103(2):75-80. PubMed ID: 12622352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carisoprodol legal status and patterns of abuse.
    Fass JA
    Ann Pharmacother; 2010 Dec; 44(12):1962-7. PubMed ID: 21062909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.
    Carbonaro TM; Nguyen V; Forster MJ; Gatch MB; Prokai L
    Neuropharmacology; 2020 Sep; 174():108152. PubMed ID: 32479814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution.
    McIntyre IM; Sherrard J; Lucas J
    J Anal Toxicol; 2012 Apr; 36(3):177-81. PubMed ID: 22417833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abuse of Carisoprodol].
    Lindberg N; Lauerma H
    Duodecim; 1996; 112(2):109-11. PubMed ID: 10590614
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.
    Bramness JG; Furu K; Skurtveit S; Engeland A
    Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of carisoprodol to breast milk.
    Nordeng H; Zahlsen K; Spigset O
    Ther Drug Monit; 2001 Jun; 23(3):298-300. PubMed ID: 11360042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is carisoprodol justified as a muscle relaxant?].
    Reiestad F; Fagerlund B
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):2041-2. PubMed ID: 11008544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.